BR112012018840A2 - proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas - Google Patents
proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmasInfo
- Publication number
- BR112012018840A2 BR112012018840A2 BR112012018840A BR112012018840A BR112012018840A2 BR 112012018840 A2 BR112012018840 A2 BR 112012018840A2 BR 112012018840 A BR112012018840 A BR 112012018840A BR 112012018840 A BR112012018840 A BR 112012018840A BR 112012018840 A2 BR112012018840 A2 BR 112012018840A2
- Authority
- BR
- Brazil
- Prior art keywords
- proteins
- vaccine
- diagnostic
- antibodies against
- methods including
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29896010P | 2010-01-28 | 2010-01-28 | |
US36098610P | 2010-07-02 | 2010-07-02 | |
PCT/SE2011/050090 WO2011093783A1 (en) | 2010-01-28 | 2011-01-28 | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012018840A2 true BR112012018840A2 (pt) | 2017-06-20 |
Family
ID=44319584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012018840A BR112012018840A2 (pt) | 2010-01-28 | 2011-01-28 | proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas |
Country Status (10)
Country | Link |
---|---|
US (1) | US8703432B2 (pt) |
EP (1) | EP2528939B1 (pt) |
JP (1) | JP2013518563A (pt) |
CN (1) | CN102918053A (pt) |
AU (1) | AU2011209988A1 (pt) |
BR (1) | BR112012018840A2 (pt) |
CA (1) | CA2825282A1 (pt) |
NZ (1) | NZ601980A (pt) |
RU (1) | RU2012137304A (pt) |
WO (1) | WO2011093783A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10010423B2 (en) | 2013-03-15 | 2018-07-03 | Avinash Kumar | Anatomical humeral fixation system and method |
EP3017814B1 (en) | 2013-07-03 | 2018-01-31 | Mitsubishi-Chemical Foods Corporation | Method for preventing and/or treating digital dermatitis |
US10022458B2 (en) | 2015-03-05 | 2018-07-17 | Iowa State University Research Foundation, Inc. | Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis |
EP3710047A1 (en) * | 2017-11-17 | 2020-09-23 | Hipra Scientific, S.L.U. | Vaccine compositions for use against digital dermatitis in a mammal |
KR102177180B1 (ko) * | 2020-05-13 | 2020-11-10 | 순천대학교 산학협력단 | 신규 트레포네마 파지데니스 균주 및 이의 분리 방법 |
KR102177181B1 (ko) * | 2020-05-14 | 2020-11-10 | 순천대학교 산학협력단 | 트레포네마 파지데니스 균주의 배양 조성물 및 이의 용도 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0534526A1 (en) * | 1991-09-25 | 1993-03-31 | Duphar International Research B.V | Treponema hyodysenteriae vaccine |
IL103530A0 (en) * | 1991-10-25 | 1993-03-15 | Duphar Int Res | Treponema hyodysenteriae vaccine |
US6096323A (en) * | 1997-10-03 | 2000-08-01 | The Regents Of The University Of California | Vaccine against papillomatous digital dermatitis (PDD) |
US6287575B1 (en) | 1997-10-03 | 2001-09-11 | The Regents Of The University Of California | Vaccine against papillomatous digital dermatitis (PDD) |
-
2011
- 2011-01-28 RU RU2012137304/10A patent/RU2012137304A/ru not_active Application Discontinuation
- 2011-01-28 EP EP11737369.6A patent/EP2528939B1/en not_active Not-in-force
- 2011-01-28 BR BR112012018840A patent/BR112012018840A2/pt not_active IP Right Cessation
- 2011-01-28 JP JP2012551129A patent/JP2013518563A/ja active Pending
- 2011-01-28 NZ NZ601980A patent/NZ601980A/en not_active IP Right Cessation
- 2011-01-28 WO PCT/SE2011/050090 patent/WO2011093783A1/en active Application Filing
- 2011-01-28 AU AU2011209988A patent/AU2011209988A1/en not_active Abandoned
- 2011-01-28 CA CA2825282A patent/CA2825282A1/en not_active Abandoned
- 2011-01-28 CN CN2011800077474A patent/CN102918053A/zh active Pending
- 2011-01-28 US US13/576,032 patent/US8703432B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20130034560A1 (en) | 2013-02-07 |
CA2825282A1 (en) | 2011-08-04 |
RU2012137304A (ru) | 2014-03-10 |
CN102918053A (zh) | 2013-02-06 |
EP2528939A4 (en) | 2013-07-03 |
WO2011093783A1 (en) | 2011-08-04 |
EP2528939B1 (en) | 2015-04-08 |
NZ601980A (en) | 2014-08-29 |
US8703432B2 (en) | 2014-04-22 |
AU2011209988A1 (en) | 2012-09-13 |
EP2528939A1 (en) | 2012-12-05 |
JP2013518563A (ja) | 2013-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261151A (en) | Water-soluble membrane proteins, methods for their preparation and use | |
HK1200489A1 (en) | Recombinant human naglu protein and uses thereof naglu | |
BR112014026990A2 (pt) | anticorpo , ácido nucleico , vetores , célula hospedeira , composição farmacêutica , uso de um anticorpo e método para o tratamento de um paciente com necessidade de terapia. | |
IL279676A (en) | Recombinant proteins and therapeutic uses | |
CO6650338A2 (es) | Antígenos de tuberculosis modificados | |
PL3604339T3 (pl) | Terapeutyczne przeciwciała przeciwko białku ror-1 i sposoby ich zastosowania | |
BR112013008410A2 (pt) | sistema para uso em reparação tecidual | |
BR112014010658A2 (pt) | antígenos e vacinas direcionadas contra enterovírus humano | |
BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
CO7000778A2 (es) | Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico | |
BR112013013756A2 (pt) | conjunto de fixação pedicular multiaxial e método de uso | |
ZA201307641B (en) | Human tissue factor antibody and uses thereof | |
BR112014010739A2 (pt) | agentes terapêuticos e uso dos mesmos | |
BR112012016229A2 (pt) | método para melhorar a sobrevida livre de progressão, método in vitro, kit, uso de um oligonucleotídeo ou polipetídeo e uso de bevacizumab | |
BR112012018840A2 (pt) | proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas | |
BR112013022285A2 (pt) | proteína de fusão de fgfr-fc e o seu uso | |
HK1198517A1 (en) | Polyoma virus jc peptides and proteins in vaccination and diagnostic applications jc | |
BR112014005406A2 (pt) | composição de vacina e respectivo uso | |
CL2015001689A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
BR112014000773A2 (pt) | composições de nicotinamida e uso terapêutico das mesmas | |
BR112013012175A2 (pt) | combinação, coadministração, uso e método | |
EP2610349A4 (en) | FULL-PIPES, PREPARATION AND USE | |
BR112013013158A2 (pt) | peptídeos de tomm34 e vacinas incluindo os mesmos | |
BR112013022164A2 (pt) | peptídeo, vacina, e, anticorpo | |
BR112013002292A2 (pt) | polipeptídeo du fusão, complexo de proteína, uso e kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |